Back

MAIT cells exacerbate liver fibrosis by downsizing the intrahepatic regulatory T cell compartment

Wang, N. I.; Shydlouskaya, V.; Reid, K. R.; Mahendran, A.; Schincaglia, A.; Keller, B. A.; Zia, S. Q.; Movasseghi, A. R.; Haruna, J.; Godfrey, D. I.; Haeryfar, S. M. M.

2026-04-19 immunology
10.64898/2026.04.15.718691 bioRxiv
Show abstract

Mucosa-associated invariant T (MAIT) cells have been paradoxically implicated in both tissue repair and fibrosis. However, when and how they modulate fibrogenesis in the injured liver remain unclear. Here, using the carbon tetrachloride-induced model of liver injury in MR1- and MAIT cell-sufficient and -deficient mice, we identify MAIT cells as an early driver of fibrogenesis. The presence of MAIT cells exacerbated hepatocellular injury, myofibroblast activation, and matrix deposition early in the course of fibrosis development, but not at later stages. This was accompanied by rapid polarization of hepatic MAIT cells toward a MAIT17 phenotype and enrichment of pro-fibrotic transcriptional programs. Concurrently, MAIT cells acquired an exhaustion-associated phenotype while still retaining their effector functions. Mechanistically, we demonstrate that MAIT cells limit hepatic regulatory T (Treg) cell accumulation, accompanied by reduced Ki-67 and CXCR3 levels in the latter population, suggesting their impaired proliferation and tissue recruitment. Furthermore, Treg cell inactivation reversed MAIT cell-dependent differences in the severity of fibrosis, establishing Treg cells as a key downstream mediator. Together, these findings identify MAIT cells as early orchestrators of fibrogenesis and reveal a novel MAIT-Treg axis that can be considered a potential therapeutic target in the early stages of fibrotic diseases.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

1
Immunity
58 papers in training set
Top 0.1%
18.5%
2
Nature Communications
4913 papers in training set
Top 17%
10.3%
3
Journal of Experimental Medicine
106 papers in training set
Top 0.2%
8.3%
4
Cell Reports
1338 papers in training set
Top 7%
6.3%
5
Journal of Clinical Investigation
164 papers in training set
Top 0.7%
4.3%
6
Nature Immunology
71 papers in training set
Top 0.6%
3.6%
50% of probability mass above
7
Journal of Hepatology
18 papers in training set
Top 0.1%
3.5%
8
Gastroenterology
40 papers in training set
Top 0.7%
2.8%
9
Science Translational Medicine
111 papers in training set
Top 1%
2.6%
10
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 25%
2.6%
11
eLife
5422 papers in training set
Top 33%
2.4%
12
Science
429 papers in training set
Top 12%
2.1%
13
Cell
370 papers in training set
Top 11%
1.8%
14
JCI Insight
241 papers in training set
Top 4%
1.7%
15
Cell Metabolism
49 papers in training set
Top 1%
1.7%
16
Gut
36 papers in training set
Top 0.5%
1.6%
17
Nature
575 papers in training set
Top 11%
1.6%
18
Nature Metabolism
56 papers in training set
Top 2%
1.5%
19
Science Immunology
81 papers in training set
Top 1%
1.5%
20
Cancer Discovery
61 papers in training set
Top 1%
1.3%
21
Science Advances
1098 papers in training set
Top 23%
1.2%
22
Cell Reports Medicine
140 papers in training set
Top 6%
1.1%
23
EMBO reports
136 papers in training set
Top 5%
0.9%
24
Molecular Cell
308 papers in training set
Top 10%
0.8%
25
Cell Host & Microbe
113 papers in training set
Top 5%
0.8%
26
Nature Cell Biology
99 papers in training set
Top 5%
0.7%
27
EMBO Molecular Medicine
85 papers in training set
Top 5%
0.7%
28
Advanced Science
249 papers in training set
Top 22%
0.6%
29
Cell Systems
167 papers in training set
Top 14%
0.6%
30
Molecular Metabolism
105 papers in training set
Top 2%
0.6%